Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022
Global revenue grew 20% year-over-year as adoption increased across all product linesAUSTIN, TX / ACCESSWIRE / May 3, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive
Source: finanznachrichten.de